184 related articles for article (PubMed ID: 37461129)
1. Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
Fukushima H; Furusawa A; Kato T; Wakiyama H; Takao S; Okuyama S; Choyke PL; Kobayashi H
Mol Cancer Ther; 2023 Oct; 22(10):1215-1227. PubMed ID: 37461129
[TBL] [Abstract][Full Text] [Related]
2. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
[TBL] [Abstract][Full Text] [Related]
3. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.
Nagaya T; Friedman J; Maruoka Y; Ogata F; Okuyama S; Clavijo PE; Choyke PL; Allen C; Kobayashi H
Cancer Immunol Res; 2019 Mar; 7(3):401-413. PubMed ID: 30683733
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.
Maruoka Y; Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927646
[TBL] [Abstract][Full Text] [Related]
5. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
[TBL] [Abstract][Full Text] [Related]
6. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
[TBL] [Abstract][Full Text] [Related]
7. Near-Infrared Photoimmunotherapy of Cancer.
Kobayashi H; Choyke PL
Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
[TBL] [Abstract][Full Text] [Related]
8. Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Choyke PL; Kobayashi H
Adv Ther (Weinh); 2021 May; 4(5):. PubMed ID: 33997271
[TBL] [Abstract][Full Text] [Related]
9. Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models.
Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32937841
[TBL] [Abstract][Full Text] [Related]
10. [Near Infrared Photoimmunotherapy for Cancer].
Kobayashi H
Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
[TBL] [Abstract][Full Text] [Related]
12. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Oncoimmunology; 2022; 11(1):2019922. PubMed ID: 35003897
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
[TBL] [Abstract][Full Text] [Related]
14. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Effectiveness of IgG Antibody versus F(ab')
Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
[TBL] [Abstract][Full Text] [Related]
16. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
17. IL15 and Anti-PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors.
Chen W; Bamford RN; Edmondson EF; Waldmann TA
Clin Cancer Res; 2022 May; 28(10):2082-2093. PubMed ID: 35262675
[TBL] [Abstract][Full Text] [Related]
18. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.
Kato T; Okada R; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Okuyama S; Fukushima H; Choyke PL; Kobayashi H
Mol Cancer Ther; 2021 Nov; 20(11):2262-2273. PubMed ID: 34518299
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.
Okada R; Furusawa A; Inagaki F; Wakiyama H; Kato T; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Sci; 2021 Aug; 112(8):3041-3049. PubMed ID: 34101947
[TBL] [Abstract][Full Text] [Related]
20. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
